Methotrexate Injection USP 25 mg

Methotrexate Injection USP 25 MG is a prescription medication used for various therapeutic purposes. This intravenous solution is manufactured by Pfizer Canada ULC and is available in multiple pack sizes.

Methotrexate Injection is commonly used for the treatment of certain types of cancer, as well as for managing severe psoriasis and rheumatoid arthritis. It works by interfering with the growth of certain cells in the body. People often ask, 'What is Methotrexate used for?' and the answer includes these broad therapeutic categories.

Common effects of Methotrexate Injection may include nausea, vomiting, and fatigue. Some individuals may experience mouth sores or hair loss. These effects can vary from person to person and are not experienced by everyone who uses this medication.

Methotrexate Injection should be handled with care and administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and schedule. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Methotrexate Injection may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.